---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-143077"
form_type: "8-K"
ticker: "PALI"
cik: "0001357459"
company_name: "PALISADE BIO, INC."
filed_at: "2022-05-06T23:59:59+00:00"
generated_at: "2026-06-25T22:54:44.803885+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Palisade Bio raises $2.0M via registered direct offering and warrants

## Summary
- 3,646,690 shares at $0.55/share for gross proceeds of ~$2.0M.
- Concurrent warrants to purchase 3,646,690 shares at $0.7105, exercisable in 6 months.
- Closing expected on or about May 10, 2022, subject to customary conditions.
- Net proceeds for working capital and development of lead candidate LB1148.
- Ladenburg Thalmann acting as exclusive placement agent.

## SEC filing metadata
- accession: 0001193125-22-143077
- form_type: 8-K
- ticker: PALI
- cik: 0001357459
- company_name: PALISADE BIO, INC.
- filed_at: 2022-05-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1357459/000119312522143077/0001193125-22-143077-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1357459/000119312522143077/d292710d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-143077
- JSON: https://secwatch.observer/filing/0001193125-22-143077.json
- Plain text: https://secwatch.observer/filing/0001193125-22-143077.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.